Meridia, a weight-loss drug. He said the agency should consider whether its benefits outweigh the risks of higher blood pressure and stroke among people taking it. “I don’t think Meridia passes that test,” Graham said.
Crestor, an anti-cholesterol drug. He said the government should evaluate the occurrence of renal failure and other serious side effects among people taking Crestor. Two of three other statin competitors prevent heart attack and stroke and do not cause renal failure, he said.
Accutane, an acne drug linked to birth defects. Graham said the drug represents a 20-year “regulatory failure” by the FDA and sales should be restricted immediately. (Bunny note – isn’t this the one also linked to causing suicidal depression in teens? Something about only being tested on adults, and then happy teens taking it, and then committing suicide? Found it: The drug is known to cause miscarriage and severe birth defects. Patients taking Accutane may develop potentially serious problems affecting a number of organs, including the liver, intestines, eyes, ears, and skeletal system. And some patients taking Accutane have developed serious psychiatric problems, including depression. More rarely, patients have developed suicidal behavior and killed themselves.
)
Bextra, a painkiller. Graham said the drug poses the same heart attack and stroke risk as Vioxx. He recommended designing studies to look at the drug’s cardiovascular risks.
Serevent, an asthma treatment. He said the drug was shown, with 90 percent certainty in a long-term trial in England, to cause deaths due to asthma. GlaxoSmithKline, told by the FDA to do a large, clinical trial, begged off. “We’ve got case reports of people dying, clutching their Serevent inhaler,” Graham said. “But Serevent is still on the market.”
Full Article